Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 30397 matches for

Last week, four researchers from Professor Leeson’s group within the Oxford Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, reached the final of the Young Investigator Awards at EuroPrevent 2015 in Lisbon.

Researchers from Cardiovascular Medicine reach the final of the Young Investigator Awards at Europrevent

Zhang Group - AI deep generative models for contrast enhancement of MRI: Towards needle-free and more informative MRI examination of the heart

Leeson Group - Developing new echocardiography diagnostics with AI

Reader Group - How do protein making factories prevent cardiovascular disease?

Simmons Group - Characterising Human Intestinal Development and Dysregulation in Childhood Diseases

Grist group - Development and combination of advanced neuroimaging to understand functional changes in Multiple Sclerosis

Vyas Group - Single Cell Biology, Molecular Mechanisms And Genetics of Transformation of Clonal Haemopoiesis to Myeloid Blood Cancer (MDS and AML)

Andersson Group - Occult hepatitis B virus infection (OBI) in people who donate blood: virology, immunology and liver health (OPAL)

Royston Group - Advanced early detection of lytic bone disease using multi-modal computational analysis of bone marrow biopsies and skeletal imaging

Ormondroyd Group - Development of genetic therapies for cardiomyopathy: creating an evidence base for ethical and clinical implementation.

Pavlides Group - Non-invasive tests for the prediction of clinical outcomes in people with metabolic dysfunction associated steatotic liver disease

NOT 2024 Vyas, Patel and Chapman Groups - Genome Instability in complex/monosomal karyotype AML (Funding Available)

Nerlov and Chapman Groups: Origins and consequences of DNA damage during haematopoietic stem cell ageing (Funding Available)

Patel, Nerlov and Vyas Groups - Metabolic genotoxicity and clonal haematopoiesis (Funding Available)

Patel, de Bruijn and Roy Groups - Impact of endogenous DNA damage and repair in early haematopoiesis

Milne, Roy and Patel Groups - DNA repair in leukaemia progression (Funding Available)

Chapman Group - Homologous recombination in genome maintenance and cancer prevention

Tyler Group - Development and Application of Hyperpolarized Magnetic Resonance Imaging in the Study of the Diseased Heart

Akbar Group - Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential.

Harvala Group - Investigations into current and future infectious threats to blood safety (deadline for application is 1st March)

MRC Enterprise Studentship - Prognostic modelling of coronary inflammation and plaque vulnerability using deep-learning of cardiac computed tomography imaging

Load More

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

New heart disease calculator could save lives by identifying high-risk patients missed by current tools

Collaborative research, led from NDPCHS and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.

Wellcome Career Development Awards for Betty Raman and Adam Wilkinson

Study will assess new MRI technique to detect liver cancer

RDM early career researchers shine in Parliamentary scientific poster competition

Professor Rury Holman wins 2024 Banting Medal for Scientific Achievement

New study provides framework for optimising the design of antibody therapeutics